PMID: 12757951May 22, 2003Paper

Sequence analysis and biochemical characterisation of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC 'FOX' cluster

FEMS Microbiology Letters
T FosseR Labia

Abstract

Aeromonas caviae CIP 74.32 was resistant to amoxicillin, ticarcillin and cephalothin, and susceptible to cefoxitin, cefotaxime, ceftazidime, aztreonam and imipenem. This strain produced a cephalosporinase (pI 7.2) and an oxacillinase (pI 8.5). The cephalosporinase gene cav-1 was cloned and sequenced. Unlike A. caviae donor, Escherichia coli pNCE50 transformant producing CAV-1 beta-lactamase was resistant to cefoxitin. The deduced protein sequence CAV-1 contained 382 amino acids, and shared >96% homology with FOX-1 to FOX-5 cephalosporinase. CAV-1 presented only two amino acid substitutions (Thr270Ser and Arg271Ala) with FOX-1. CAV-1 is the chromosomal putative ancestor of the FOX family, a cluster of class C/group 1 plasmidic cephalosporinases spreading in Klebsiella and E. coli clinical isolates via conjugative plasmids.

References

May 1, 1976·Journal of General Microbiology·M Popoff, M Véron
May 1, 1992·Journal of Clinical Microbiology·S L AbbottJ M Janda
Feb 1, 1990·Journal of Clinical Microbiology·M AltweggD J Brenner
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Apr 1, 1996·International Journal of Systematic Bacteriology·G HuysK Kersters
Jul 1, 1997·FEMS Microbiology Letters·J M PembertonR Schmidt
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·A BauernfeindD Meyer
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A Jacoby
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J M Janda, S L Abbott
Dec 18, 2002·Letters in Applied Microbiology·T FosseI Madinier
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·R M Hall, C M Collis

❮ Previous
Next ❯

Citations

Mar 1, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B LamyH Marchandin
Feb 4, 2010·Antimicrobial Agents and Chemotherapy·Filomena De LucaThierry Fosse
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Hedi MammeriPatrice Nordmann
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Mark D Reisbig, Nancy D Hanson
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George A Jacoby
Dec 4, 2012·Applied and Environmental Microbiology·Veiko VoolaidVeljo Kisand
Jan 13, 2009·Clinical Microbiology Reviews·George A Jacoby
Jan 13, 2010·Clinical Microbiology Reviews·J Michael Janda, Sharon L Abbott
Jul 31, 2007·Future Microbiology·Gian Maria Rossolini, Jean-Denis Docquier
Oct 4, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Po-Lin ChenChi-Jung Wu
May 14, 2011·FEMS Microbiology Reviews·Sally R Partridge
Mar 24, 2006·FEMS Microbiology Letters·Hedi MammeriPatrice Nordmann
Jun 16, 2005·Expert Review of Anti-infective Therapy·Miranda BatchelorErnesto Liebana
Feb 15, 2018·Antimicrobial Agents and Chemotherapy·Michiyoshi NukagaRobert A Bonomo
Jul 18, 2018·Polish Journal of Microbiology·Uttara Dey Bhowmick, Soumen Bhattacharjee
Aug 20, 2019·Applied and Environmental Microbiology·Chi-Jung WuPo-Lin Chen
May 22, 2018·BioMed Research International·Sadeeq Ur RahmanJian Gao
Jan 6, 2021·Communications Biology·Stefan EbmeyerD G Joakim Larsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.